|
|
|
4553 TOWA PHARMACEUTICAL CO.,LTD.
|
|
| 10/30/2026 15:30 |
(Change in Disclosure Information) Notice of Change in the Date of Execution of the Share Transfer Concerning the Acquisition of Shares |
| 08/06/2026 15:30 |
Supplementary material for the financial results for the first quarter of the year ending March 31, 2027 |
| 08/06/2026 15:30 |
Consolidated Financial Results for the Three Months Ended June 30, 2026 (Based on Japanese GAAP) |
| 07/31/2026 15:30 |
Notice of Completion of Payment for the Issuance of 1st Series Class A Preferred Shares through Third-Party Allotment |
| 07/10/2026 15:30 |
Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation |
| 07/03/2026 16:00 |
Notice of Acquisition of Shares of Tanabe Pharma Factory Co., Ltd. and Transfer of Manufacturing and Marketing Approvals |
| 06/24/2026 15:30 |
Notice of Disposal of Treasury Shares as Restricted Stock Compensation |
| 06/24/2026 15:30 |
Notice of Changes in Officers |
| 06/24/2026 15:30 |
Matters Related to Controlling Shareholders |
| 06/24/2026 15:30 |
Notice of Financial Results of Parent Company, etc. |
| 05/29/2026 08:00 |
NOTICE OF THE 70TH ORDINARY GENERAL MEETING OF SHAREHOLDERS |
| 05/21/2026 16:30 |
Notice of Issuance of Class A Preferred Shares through Third-Party Allotment |
| 05/21/2026 16:30 |
Notice of Changes in Officers |
| 05/14/2026 15:30 |
Consolidated Financial Results for the Year Ended March 31, 2026 (Based on Japanese GAAP) |
| 05/14/2026 15:30 |
Supplementary material for the financial results for the year ended March 31, 2026 |
| 05/11/2026 15:30 |
Notice of Recognition of an Impairment Loss and a Loss on Valuation of Shares of Subsidiaries and Associates, and Revisions of Financial Forecasts |
| 02/13/2026 15:30 |
Supplementary material for the financial results for the third quarter of the year ending March 31, 2026 |
| 02/13/2026 15:30 |
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP) |
| 01/21/2026 15:30 |
Notice of Conclusion of a Basic Agreement with Otsuka Pharmaceutical to Establish a Collaborative Framework for Pharmaceutical Manufacturing |
| 12/23/2025 00:30 |
TOWA PHARMACEUTICAL INTEGRATED REPORT 2025 |
| 11/10/2025 15:30 |
Supplementary material for the financial results for the second quarter (interim period) of the year ending March 31, 2026 |
| 11/10/2025 15:30 |
Consolidated Financial Results for the Six Months Ended September 30, 2025 (Based on Japanese GAAP) |
|
